English
简体中文
Total: £ 56.28
Published Date: 2024-10-17 | Pages: 158 | Tables: 277 | Medical Care
Transformation of bacteria with plasmids is important because bacteria are used as the means for both storing and replicating plasmids. E. coli cells are more likely to incorporate foreign DNA if their cell walls are altered so that DNA can pass through more easily. Such cells are said to be "competent."
The global market for Competent E.coli was estimated to be worth US$ 115 million in 2023 and is forecast to a readjusted size of US$ 151.8 million by 2030 with a CAGR of 4.0% during the forecast period 2024-2030
North American market for Competent E.coli was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Competent E.coli was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Competent E.coli was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Competent E.coli include Thermo Fisher Scientific Inc, Promega, Merck KGaA, New England Biolabs, Agilent Technologies, Takara Bio, Edge BioSystems, TransGen Biotech and Nanjing GenScript Biotechnology, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Competent E.coli, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Competent E.coli by region & country, by Type, and by Application.
The Competent E.coli market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Competent E.coli.
Market Segmentation
By Company
Thermo Fisher Scientific Inc
Promega
Merck KGaA
New England Biolabs
Agilent Technologies
Takara Bio
Edge BioSystems
TransGen Biotech
Nanjing GenScript Biotechnology
GCC Biotech
SMOBIO Technology
QIAGEN N.V.
OriGene
Lucigen
Zymo Research
Bio-Rad Laboratories
Bioline
Delphi Genetics
IBA GmBH
Cell Applications
BioDynamics Laboratory
Scarab Genomics
Segment by Type:
Chemically Competent Cells
Electrocompetent Cells
Segment by Application
Molecular Cloning
Plasmid Extraction
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Competent E.coli manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Competent E.coli in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Competent E.coli in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 Competent E.coli Product Introduction
1.2 Global Competent E.coli Market Size Forecast
1.2.1 Global Competent E.coli Sales Value (2019-2030)
1.2.2 Global Competent E.coli Sales Volume (2019-2030)
1.2.3 Global Competent E.coli Sales Price (2019-2030)
1.3 Competent E.coli Market Trends & Drivers
1.3.1 Competent E.coli Industry Trends
1.3.2 Competent E.coli Market Drivers & Opportunity
1.3.3 Competent E.coli Market Challenges
1.3.4 Competent E.coli Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Competent E.coli Players Revenue Ranking (2023)
2.2 Global Competent E.coli Revenue by Company (2019-2024)
2.3 Global Competent E.coli Players Sales Volume Ranking (2023)
2.4 Global Competent E.coli Sales Volume by Company Players (2019-2024)
2.5 Global Competent E.coli Average Price by Company (2019-2024)
2.6 Key Manufacturers Competent E.coli Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Competent E.coli Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Competent E.coli
2.9 Competent E.coli Market Competitive Analysis
2.9.1 Competent E.coli Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Competent E.coli Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Competent E.coli as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Chemically Competent Cells
3.1.2 Electrocompetent Cells
3.2 Global Competent E.coli Sales Value by Type
3.2.1 Global Competent E.coli Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Competent E.coli Sales Value, by Type (2019-2030)
3.2.3 Global Competent E.coli Sales Value, by Type (%) (2019-2030)
3.3 Global Competent E.coli Sales Volume by Type
3.3.1 Global Competent E.coli Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Competent E.coli Sales Volume, by Type (2019-2030)
3.3.3 Global Competent E.coli Sales Volume, by Type (%) (2019-2030)
3.4 Global Competent E.coli Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Molecular Cloning
4.1.2 Plasmid Extraction
4.1.3 Other
4.2 Global Competent E.coli Sales Value by Application
4.2.1 Global Competent E.coli Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Competent E.coli Sales Value, by Application (2019-2030)
4.2.3 Global Competent E.coli Sales Value, by Application (%) (2019-2030)
4.3 Global Competent E.coli Sales Volume by Application
4.3.1 Global Competent E.coli Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Competent E.coli Sales Volume, by Application (2019-2030)
4.3.3 Global Competent E.coli Sales Volume, by Application (%) (2019-2030)
4.4 Global Competent E.coli Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Competent E.coli Sales Value by Region
5.1.1 Global Competent E.coli Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Competent E.coli Sales Value by Region (2019-2024)
5.1.3 Global Competent E.coli Sales Value by Region (2025-2030)
5.1.4 Global Competent E.coli Sales Value by Region (%), (2019-2030)
5.2 Global Competent E.coli Sales Volume by Region
5.2.1 Global Competent E.coli Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Competent E.coli Sales Volume by Region (2019-2024)
5.2.3 Global Competent E.coli Sales Volume by Region (2025-2030)
5.2.4 Global Competent E.coli Sales Volume by Region (%), (2019-2030)
5.3 Global Competent E.coli Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Competent E.coli Sales Value, 2019-2030
5.4.2 North America Competent E.coli Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Competent E.coli Sales Value, 2019-2030
5.5.2 Europe Competent E.coli Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Competent E.coli Sales Value, 2019-2030
5.6.2 Asia Pacific Competent E.coli Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Competent E.coli Sales Value, 2019-2030
5.7.2 South America Competent E.coli Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Competent E.coli Sales Value, 2019-2030
5.8.2 Middle East & Africa Competent E.coli Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Competent E.coli Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Competent E.coli Sales Value
6.2.1 Key Countries/Regions Competent E.coli Sales Value, 2019-2030
6.2.2 Key Countries/Regions Competent E.coli Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Competent E.coli Sales Value, 2019-2030
6.3.2 United States Competent E.coli Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Competent E.coli Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Competent E.coli Sales Value, 2019-2030
6.4.2 Europe Competent E.coli Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Competent E.coli Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Competent E.coli Sales Value, 2019-2030
6.5.2 China Competent E.coli Sales Value by Type (%), 2023 VS 2030
6.5.3 China Competent E.coli Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Competent E.coli Sales Value, 2019-2030
6.6.2 Japan Competent E.coli Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Competent E.coli Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Competent E.coli Sales Value, 2019-2030
6.7.2 South Korea Competent E.coli Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Competent E.coli Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Competent E.coli Sales Value, 2019-2030
6.8.2 Southeast Asia Competent E.coli Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Competent E.coli Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Competent E.coli Sales Value, 2019-2030
6.9.2 India Competent E.coli Sales Value by Type (%), 2023 VS 2030
6.9.3 India Competent E.coli Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Thermo Fisher Scientific Inc
7.1.1 Thermo Fisher Scientific Inc Company Information
7.1.2 Thermo Fisher Scientific Inc Introduction and Business Overview
7.1.3 Thermo Fisher Scientific Inc Competent E.coli Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Thermo Fisher Scientific Inc Competent E.coli Product Offerings
7.1.5 Thermo Fisher Scientific Inc Recent Development
7.2 Promega
7.2.1 Promega Company Information
7.2.2 Promega Introduction and Business Overview
7.2.3 Promega Competent E.coli Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Promega Competent E.coli Product Offerings
7.2.5 Promega Recent Development
7.3 Merck KGaA
7.3.1 Merck KGaA Company Information
7.3.2 Merck KGaA Introduction and Business Overview
7.3.3 Merck KGaA Competent E.coli Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Merck KGaA Competent E.coli Product Offerings
7.3.5 Merck KGaA Recent Development
7.4 New England Biolabs
7.4.1 New England Biolabs Company Information
7.4.2 New England Biolabs Introduction and Business Overview
7.4.3 New England Biolabs Competent E.coli Sales, Revenue and Gross Margin (2019-2024)
7.4.4 New England Biolabs Competent E.coli Product Offerings
7.4.5 New England Biolabs Recent Development
7.5 Agilent Technologies
7.5.1 Agilent Technologies Company Information
7.5.2 Agilent Technologies Introduction and Business Overview
7.5.3 Agilent Technologies Competent E.coli Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Agilent Technologies Competent E.coli Product Offerings
7.5.5 Agilent Technologies Recent Development
7.6 Takara Bio
7.6.1 Takara Bio Company Information
7.6.2 Takara Bio Introduction and Business Overview
7.6.3 Takara Bio Competent E.coli Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Takara Bio Competent E.coli Product Offerings
7.6.5 Takara Bio Recent Development
7.7 Edge BioSystems
7.7.1 Edge BioSystems Company Information
7.7.2 Edge BioSystems Introduction and Business Overview
7.7.3 Edge BioSystems Competent E.coli Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Edge BioSystems Competent E.coli Product Offerings
7.7.5 Edge BioSystems Recent Development
7.8 TransGen Biotech
7.8.1 TransGen Biotech Company Information
7.8.2 TransGen Biotech Introduction and Business Overview
7.8.3 TransGen Biotech Competent E.coli Sales, Revenue and Gross Margin (2019-2024)
7.8.4 TransGen Biotech Competent E.coli Product Offerings
7.8.5 TransGen Biotech Recent Development
7.9 Nanjing GenScript Biotechnology
7.9.1 Nanjing GenScript Biotechnology Company Information
7.9.2 Nanjing GenScript Biotechnology Introduction and Business Overview
7.9.3 Nanjing GenScript Biotechnology Competent E.coli Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Nanjing GenScript Biotechnology Competent E.coli Product Offerings
7.9.5 Nanjing GenScript Biotechnology Recent Development
7.10 GCC Biotech
7.10.1 GCC Biotech Company Information
7.10.2 GCC Biotech Introduction and Business Overview
7.10.3 GCC Biotech Competent E.coli Sales, Revenue and Gross Margin (2019-2024)
7.10.4 GCC Biotech Competent E.coli Product Offerings
7.10.5 GCC Biotech Recent Development
7.11 SMOBIO Technology
7.11.1 SMOBIO Technology Company Information
7.11.2 SMOBIO Technology Introduction and Business Overview
7.11.3 SMOBIO Technology Competent E.coli Sales, Revenue and Gross Margin (2019-2024)
7.11.4 SMOBIO Technology Competent E.coli Product Offerings
7.11.5 SMOBIO Technology Recent Development
7.12 QIAGEN N.V.
7.12.1 QIAGEN N.V. Company Information
7.12.2 QIAGEN N.V. Introduction and Business Overview
7.12.3 QIAGEN N.V. Competent E.coli Sales, Revenue and Gross Margin (2019-2024)
7.12.4 QIAGEN N.V. Competent E.coli Product Offerings
7.12.5 QIAGEN N.V. Recent Development
7.13 OriGene
7.13.1 OriGene Company Information
7.13.2 OriGene Introduction and Business Overview
7.13.3 OriGene Competent E.coli Sales, Revenue and Gross Margin (2019-2024)
7.13.4 OriGene Competent E.coli Product Offerings
7.13.5 OriGene Recent Development
7.14 Lucigen
7.14.1 Lucigen Company Information
7.14.2 Lucigen Introduction and Business Overview
7.14.3 Lucigen Competent E.coli Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Lucigen Competent E.coli Product Offerings
7.14.5 Lucigen Recent Development
7.15 Zymo Research
7.15.1 Zymo Research Company Information
7.15.2 Zymo Research Introduction and Business Overview
7.15.3 Zymo Research Competent E.coli Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Zymo Research Competent E.coli Product Offerings
7.15.5 Zymo Research Recent Development
7.16 Bio-Rad Laboratories
7.16.1 Bio-Rad Laboratories Company Information
7.16.2 Bio-Rad Laboratories Introduction and Business Overview
7.16.3 Bio-Rad Laboratories Competent E.coli Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Bio-Rad Laboratories Competent E.coli Product Offerings
7.16.5 Bio-Rad Laboratories Recent Development
7.17 Bioline
7.17.1 Bioline Company Information
7.17.2 Bioline Introduction and Business Overview
7.17.3 Bioline Competent E.coli Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Bioline Competent E.coli Product Offerings
7.17.5 Bioline Recent Development
7.18 Delphi Genetics
7.18.1 Delphi Genetics Company Information
7.18.2 Delphi Genetics Introduction and Business Overview
7.18.3 Delphi Genetics Competent E.coli Sales, Revenue and Gross Margin (2019-2024)
7.18.4 Delphi Genetics Competent E.coli Product Offerings
7.18.5 Delphi Genetics Recent Development
7.19 IBA GmBH
7.19.1 IBA GmBH Company Information
7.19.2 IBA GmBH Introduction and Business Overview
7.19.3 IBA GmBH Competent E.coli Sales, Revenue and Gross Margin (2019-2024)
7.19.4 IBA GmBH Competent E.coli Product Offerings
7.19.5 IBA GmBH Recent Development
7.20 Cell Applications
7.20.1 Cell Applications Company Information
7.20.2 Cell Applications Introduction and Business Overview
7.20.3 Cell Applications Competent E.coli Sales, Revenue and Gross Margin (2019-2024)
7.20.4 Cell Applications Competent E.coli Product Offerings
7.20.5 Cell Applications Recent Development
7.21 BioDynamics Laboratory
7.21.1 BioDynamics Laboratory Company Information
7.21.2 BioDynamics Laboratory Introduction and Business Overview
7.21.3 BioDynamics Laboratory Competent E.coli Sales, Revenue and Gross Margin (2019-2024)
7.21.4 BioDynamics Laboratory Competent E.coli Product Offerings
7.21.5 BioDynamics Laboratory Recent Development
7.22 Scarab Genomics
7.22.1 Scarab Genomics Company Information
7.22.2 Scarab Genomics Introduction and Business Overview
7.22.3 Scarab Genomics Competent E.coli Sales, Revenue and Gross Margin (2019-2024)
7.22.4 Scarab Genomics Competent E.coli Product Offerings
7.22.5 Scarab Genomics Recent Development
8 Industry Chain Analysis
8.1 Competent E.coli Industrial Chain
8.2 Competent E.coli Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Competent E.coli Sales Model
8.5.2 Sales Channel
8.5.3 Competent E.coli Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Competent E.coli Market Trends
Table 2. Competent E.coli Market Drivers & Opportunity
Table 3. Competent E.coli Market Challenges
Table 4. Competent E.coli Market Restraints
Table 5. Global Competent E.coli Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Competent E.coli Revenue Market Share by Company (2019-2024)
Table 7. Global Competent E.coli Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Competent E.coli Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Competent E.coli Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Competent E.coli Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Competent E.coli Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Competent E.coli
Table 13. Global Competent E.coli Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Competent E.coli as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Competent E.coli Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Competent E.coli Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Competent E.coli Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Competent E.coli Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Competent E.coli Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Competent E.coli Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Competent E.coli Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Competent E.coli Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Competent E.coli Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Competent E.coli Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Competent E.coli Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Competent E.coli Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Competent E.coli Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Competent E.coli Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Competent E.coli Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Competent E.coli Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Competent E.coli Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Competent E.coli Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Competent E.coli Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Competent E.coli Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Competent E.coli Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Competent E.coli Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Competent E.coli Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Competent E.coli Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Competent E.coli Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Competent E.coli Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Competent E.coli Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Competent E.coli Sales Value by Region (2019-2024) & (%)
Table 44. Global Competent E.coli Sales Value by Region (2025-2030) & (%)
Table 45. Global Competent E.coli Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Competent E.coli Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Competent E.coli Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Competent E.coli Sales Volume by Region (2019-2024) & (%)
Table 49. Global Competent E.coli Sales Volume by Region (2025-2030) & (%)
Table 50. Global Competent E.coli Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Competent E.coli Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Competent E.coli Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Competent E.coli Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Competent E.coli Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Competent E.coli Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Competent E.coli Sales Volume, (2025-2030) & (K Units)
Table 57. Thermo Fisher Scientific Inc Company Information
Table 58. Thermo Fisher Scientific Inc Introduction and Business Overview
Table 59. Thermo Fisher Scientific Inc Competent E.coli Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Thermo Fisher Scientific Inc Competent E.coli Product Offerings
Table 61. Thermo Fisher Scientific Inc Recent Development
Table 62. Promega Company Information
Table 63. Promega Introduction and Business Overview
Table 64. Promega Competent E.coli Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. Promega Competent E.coli Product Offerings
Table 66. Promega Recent Development
Table 67. Merck KGaA Company Information
Table 68. Merck KGaA Introduction and Business Overview
Table 69. Merck KGaA Competent E.coli Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. Merck KGaA Competent E.coli Product Offerings
Table 71. Merck KGaA Recent Development
Table 72. New England Biolabs Company Information
Table 73. New England Biolabs Introduction and Business Overview
Table 74. New England Biolabs Competent E.coli Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. New England Biolabs Competent E.coli Product Offerings
Table 76. New England Biolabs Recent Development
Table 77. Agilent Technologies Company Information
Table 78. Agilent Technologies Introduction and Business Overview
Table 79. Agilent Technologies Competent E.coli Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Agilent Technologies Competent E.coli Product Offerings
Table 81. Agilent Technologies Recent Development
Table 82. Takara Bio Company Information
Table 83. Takara Bio Introduction and Business Overview
Table 84. Takara Bio Competent E.coli Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Takara Bio Competent E.coli Product Offerings
Table 86. Takara Bio Recent Development
Table 87. Edge BioSystems Company Information
Table 88. Edge BioSystems Introduction and Business Overview
Table 89. Edge BioSystems Competent E.coli Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Edge BioSystems Competent E.coli Product Offerings
Table 91. Edge BioSystems Recent Development
Table 92. TransGen Biotech Company Information
Table 93. TransGen Biotech Introduction and Business Overview
Table 94. TransGen Biotech Competent E.coli Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. TransGen Biotech Competent E.coli Product Offerings
Table 96. TransGen Biotech Recent Development
Table 97. Nanjing GenScript Biotechnology Company Information
Table 98. Nanjing GenScript Biotechnology Introduction and Business Overview
Table 99. Nanjing GenScript Biotechnology Competent E.coli Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. Nanjing GenScript Biotechnology Competent E.coli Product Offerings
Table 101. Nanjing GenScript Biotechnology Recent Development
Table 102. GCC Biotech Company Information
Table 103. GCC Biotech Introduction and Business Overview
Table 104. GCC Biotech Competent E.coli Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. GCC Biotech Competent E.coli Product Offerings
Table 106. GCC Biotech Recent Development
Table 107. SMOBIO Technology Company Information
Table 108. SMOBIO Technology Introduction and Business Overview
Table 109. SMOBIO Technology Competent E.coli Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. SMOBIO Technology Competent E.coli Product Offerings
Table 111. SMOBIO Technology Recent Development
Table 112. QIAGEN N.V. Company Information
Table 113. QIAGEN N.V. Introduction and Business Overview
Table 114. QIAGEN N.V. Competent E.coli Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. QIAGEN N.V. Competent E.coli Product Offerings
Table 116. QIAGEN N.V. Recent Development
Table 117. OriGene Company Information
Table 118. OriGene Introduction and Business Overview
Table 119. OriGene Competent E.coli Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 120. OriGene Competent E.coli Product Offerings
Table 121. OriGene Recent Development
Table 122. Lucigen Company Information
Table 123. Lucigen Introduction and Business Overview
Table 124. Lucigen Competent E.coli Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 125. Lucigen Competent E.coli Product Offerings
Table 126. Lucigen Recent Development
Table 127. Zymo Research Company Information
Table 128. Zymo Research Introduction and Business Overview
Table 129. Zymo Research Competent E.coli Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 130. Zymo Research Competent E.coli Product Offerings
Table 131. Zymo Research Recent Development
Table 132. Bio-Rad Laboratories Company Information
Table 133. Bio-Rad Laboratories Introduction and Business Overview
Table 134. Bio-Rad Laboratories Competent E.coli Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 135. Bio-Rad Laboratories Competent E.coli Product Offerings
Table 136. Bio-Rad Laboratories Recent Development
Table 137. Bioline Company Information
Table 138. Bioline Introduction and Business Overview
Table 139. Bioline Competent E.coli Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 140. Bioline Competent E.coli Product Offerings
Table 141. Bioline Recent Development
Table 142. Delphi Genetics Company Information
Table 143. Delphi Genetics Introduction and Business Overview
Table 144. Delphi Genetics Competent E.coli Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 145. Delphi Genetics Competent E.coli Product Offerings
Table 146. Delphi Genetics Recent Development
Table 147. IBA GmBH Company Information
Table 148. IBA GmBH Introduction and Business Overview
Table 149. IBA GmBH Competent E.coli Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 150. IBA GmBH Competent E.coli Product Offerings
Table 151. IBA GmBH Recent Development
Table 152. Cell Applications Company Information
Table 153. Cell Applications Introduction and Business Overview
Table 154. Cell Applications Competent E.coli Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 155. Cell Applications Competent E.coli Product Offerings
Table 156. Cell Applications Recent Development
Table 157. BioDynamics Laboratory Company Information
Table 158. BioDynamics Laboratory Introduction and Business Overview
Table 159. BioDynamics Laboratory Competent E.coli Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 160. BioDynamics Laboratory Competent E.coli Product Offerings
Table 161. BioDynamics Laboratory Recent Development
Table 162. Scarab Genomics Company Information
Table 163. Scarab Genomics Introduction and Business Overview
Table 164. Scarab Genomics Competent E.coli Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 165. Scarab Genomics Competent E.coli Product Offerings
Table 166. Scarab Genomics Recent Development
Table 167. Key Raw Materials Lists
Table 168. Raw Materials Key Suppliers Lists
Table 169. Competent E.coli Downstream Customers
Table 170. Competent E.coli Distributors List
Table 171. Research Programs/Design for This Report
Table 172. Key Data Information from Secondary Sources
Table 173. Key Data Information from Primary Sources
List of Figures
Figure 1. Competent E.coli Product Picture
Figure 2. Global Competent E.coli Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Competent E.coli Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Competent E.coli Sales Volume (2019-2030) & (K Units)
Figure 5. Global Competent E.coli Sales Price (2019-2030) & (US$/Unit)
Figure 6. Competent E.coli Report Years Considered
Figure 7. Global Competent E.coli Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Competent E.coli Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Competent E.coli Revenue in 2023
Figure 10. Competent E.coli Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Chemically Competent Cells Picture
Figure 12. Electrocompetent Cells Picture
Figure 13. Global Competent E.coli Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Competent E.coli Sales Value Market Share by Type, 2023 & 2030
Figure 15. Global Competent E.coli Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 16. Global Competent E.coli Sales Volume Market Share by Type, 2023 & 2030
Figure 17. Global Competent E.coli Price by Type (2019-2030) & (US$/Unit)
Figure 18. Product Picture of Molecular Cloning
Figure 19. Product Picture of Plasmid Extraction
Figure 20. Product Picture of Other
Figure 21. Global Competent E.coli Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 22. Global Competent E.coli Sales Value Market Share by Application, 2023 & 2030
Figure 23. Global Competent E.coli Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 24. Global Competent E.coli Sales Volume Market Share by Application, 2023 & 2030
Figure 25. Global Competent E.coli Price by Application (2019-2030) & (US$/Unit)
Figure 26. North America Competent E.coli Sales Value (2019-2030) & (US$ Million)
Figure 27. North America Competent E.coli Sales Value by Country (%), 2023 VS 2030
Figure 28. Europe Competent E.coli Sales Value (2019-2030) & (US$ Million)
Figure 29. Europe Competent E.coli Sales Value by Country (%), 2023 VS 2030
Figure 30. Asia Pacific Competent E.coli Sales Value (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Competent E.coli Sales Value by Country (%), 2023 VS 2030
Figure 32. South America Competent E.coli Sales Value (2019-2030) & (US$ Million)
Figure 33. South America Competent E.coli Sales Value by Country (%), 2023 VS 2030
Figure 34. Middle East & Africa Competent E.coli Sales Value (2019-2030) & (US$ Million)
Figure 35. Middle East & Africa Competent E.coli Sales Value by Country (%), 2023 VS 2030
Figure 36. Key Countries/Regions Competent E.coli Sales Value (%), (2019-2030)
Figure 37. Key Countries/Regions Competent E.coli Sales Volume (%), (2019-2030)
Figure 38. United States Competent E.coli Sales Value, (2019-2030) & (US$ Million)
Figure 39. United States Competent E.coli Sales Value by Type (%), 2023 VS 2030
Figure 40. United States Competent E.coli Sales Value by Application (%), 2023 VS 2030
Figure 41. Europe Competent E.coli Sales Value, (2019-2030) & (US$ Million)
Figure 42. Europe Competent E.coli Sales Value by Type (%), 2023 VS 2030
Figure 43. Europe Competent E.coli Sales Value by Application (%), 2023 VS 2030
Figure 44. China Competent E.coli Sales Value, (2019-2030) & (US$ Million)
Figure 45. China Competent E.coli Sales Value by Type (%), 2023 VS 2030
Figure 46. China Competent E.coli Sales Value by Application (%), 2023 VS 2030
Figure 47. Japan Competent E.coli Sales Value, (2019-2030) & (US$ Million)
Figure 48. Japan Competent E.coli Sales Value by Type (%), 2023 VS 2030
Figure 49. Japan Competent E.coli Sales Value by Application (%), 2023 VS 2030
Figure 50. South Korea Competent E.coli Sales Value, (2019-2030) & (US$ Million)
Figure 51. South Korea Competent E.coli Sales Value by Type (%), 2023 VS 2030
Figure 52. South Korea Competent E.coli Sales Value by Application (%), 2023 VS 2030
Figure 53. Southeast Asia Competent E.coli Sales Value, (2019-2030) & (US$ Million)
Figure 54. Southeast Asia Competent E.coli Sales Value by Type (%), 2023 VS 2030
Figure 55. Southeast Asia Competent E.coli Sales Value by Application (%), 2023 VS 2030
Figure 56. India Competent E.coli Sales Value, (2019-2030) & (US$ Million)
Figure 57. India Competent E.coli Sales Value by Type (%), 2023 VS 2030
Figure 58. India Competent E.coli Sales Value by Application (%), 2023 VS 2030
Figure 59. Competent E.coli Industrial Chain
Figure 60. Competent E.coli Manufacturing Cost Structure
Figure 61. Channels of Distribution (Direct Sales, and Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
